Donal A. Walsh

Donal A. Walsh's AcademicInfluence.com Rankings

Donal A. Walsh

Biology

#12029

World Rank

#15477

Historical Rank

Biochemistry

#2024

World Rank

#2166

Historical Rank

biology Degrees

Download Badge

Biology

Donal A. Walsh's Degrees

PhD Biochemistry University of California, Berkeley
Bachelors Chemistry Stanford University

Why Is Donal A. Walsh Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Donal A. Walsh's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

An adenosine 3',5'-monophosphate-dependant protein kinase from rabbit skeletal muscle. (1968) (1134)
Purification and Characterization of a Protein Inhibitor of Adenosine 3',5'-Monophosphate-dependent Protein Kinases (1971) (637)
Purification and properties of rabbit skeletal muscle adenosine 3',5'-monophosphate-dependent protein kinases. (1971) (567)
A potent synthetic peptide inhibitor of the cAMP-dependent protein kinase. (1986) (508)
Inactivation of glycogen synthetase and activation of phosphorylase kinase by muscle adenosine 3',5'-monophosphate-dependent protein kinases. (1970) (270)
Primary structural determinants essential for potent inhibition of cAMP-dependent protein kinase by inhibitory peptides corresponding to the active portion of the heat-stable inhibitor protein. (1989) (245)
Multiple pathway signal tran sduction by the cAMP‐dependent protein kinase (1994) (241)
Characterization of the interaction of a protein inhibitor with adenosine 3',5'-monophosphate-dependent protein kinases. I. Interaction with the catalytic subunit of the protein kinase. (1972) (226)
Catalysis of the Phosphorylase Kinase Activation Reaction (1971) (190)
Activation of adipose tissue lipase by skeletal muscle cyclic adenosine 3',5'- monophosphate-stimulated protein kinase. (1970) (165)
Phosphorylase kinase: the complexity of its regulation is reflected in the complexity of its structure. (1999) (156)
A cyclic 3',5'-amp-stimulated protein kinase from cardiac muscle. (1970) (148)
Studies on the kinetic mechanism of the catalytic subunit of the cAMP-dependent protein kinase. (1983) (147)
The catalytic subunit of cAMP-dependent protein kinase induces expression of genes containing cAMP-responsive enhancer elements (1988) (145)
Characterization of the interaction of a protein inhibitor with adenosine 3',5'-monophosphate-dependent protein kinases. II. Mechanism of action with the holoenzyme. (1973) (121)
Mg X ATP2-dependent interaction of the inhibitor protein of the cAMP-dependent protein kinase with the catalytic subunit. (1983) (116)
Phosphorylation of Avena phytochrome in vitro as a probe of light-induced conformational changes. (1986) (115)
Physiochemical properties of rabbit skeletal muscle phosphorylase kinase. (1973) (115)
Protein kinase inhibitor-(6-22)-amide peptide analogs with standard and nonstandard amino acid substitutions for phenylalanine 10. Inhibition of cAMP-dependent protein kinase. (1989) (112)
Protein kinases: aspects of their regulation and diversity. (1973) (110)
Multiple forms of hepatic adenosine 3':5'-monophosphate dependent protein kinase. (1971) (105)
Differential and common recognition of the catalytic sites of the cGMP-dependent and cAMP-dependent protein kinases by inhibitory peptides derived from the heat-stable inhibitor protein. (1986) (99)
Comparative studies on the pathways for serine biosynthesis in animal tissues. (1966) (96)
Measurement of cyclic 3',5'-denosine monophosphate by the activation of skeletal muscle protein kinase. (1971) (91)
An active twenty-amino-acid-residue peptide derived from the inhibitor protein of the cyclic AMP-dependent protein kinase. (1985) (89)
Kinetics and mechanism of hydrolysis of a silicate triester, tris(2-methoxyethoxy)phenylsilane (1980) (75)
Solution structure of the cAMP-dependent protein kinase catalytic subunit and its contraction upon binding the protein kinase inhibitor peptide. (1993) (68)
The elementary reactions of the pig heart pyruvate dehydrogenase complex. A study of the inhibition by phosphorylation. (1976) (66)
Critical controls in the evaluation of cAMP-dependent protein kinase activity ratios as indices of hormonal action. (1980) (64)
The cyclin-dependent kinase (CDK) inhibitor flavopiridol inhibits glycogen phosphorylase. (2001) (57)
Progressive Cyclic Nucleotide-induced Conformational Changes in the cGMP-dependent Protein Kinase Studied by Small Angle X-ray Scattering in Solution* (1997) (57)
Nuclear protein-kinase activity in perfused rat liver stimulated with dibutyryl-adenosine cyclic 3':5'-monophosphate. (1975) (56)
The interrelationship between cAMP-dependent alpha and beta subunit phosphorylation in the regulation of phosphorylase kinase activity. Studies using subunit specific phosphatases. (1987) (55)
Quaternary Structures of a Catalytic Subunit-Regulatory Subunit Dimeric Complex and the Holoenzyme of the cAMP-dependent Protein Kinase by Neutron Contrast Variation* (1998) (55)
[48] Purification and characterization of an inhibitor protein of cyclic AMP-dependent protein kinases (1974) (53)
Cyclic adenosine monophosphate dependent and independent phosphorylation of sarcolemma membrane proteins in perfused rat heart. (1979) (52)
The inhibitor protein of the cAMP-dependent protein kinase-catalytic subunit interaction. Parameters of complex formation. (1986) (52)
Peptide inhibitors of cAMP-dependent protein kinase. (1988) (51)
Purification and properties of chicken liver D-3-phosphoglycerate dehydrogenase. (1965) (51)
Heat-stable inhibitor protein derived peptide substrate analogs: phosphorylation by cAMP-dependent and cGMP-dependent protein kinases. (1995) (50)
In situ regulation of cell-cell communication by the cAMP-dependent protein kinase and protein kinase C (1993) (46)
Autophosphorylation of the catalytic subunit of cAMP-dependent protein kinase. (1992) (46)
Nuclear protein kinase activity in glucagon-stimulated perfused rat livers. (1974) (46)
A fast-twitch oxidative-glycolytic muscle with a robust inward calcium current. (1985) (46)
Phosphorylation of high-mobility-group proteins by the calcium-phospholipid-dependent protein kinase and the cyclic AMP-dependent protein kinase. (1984) (45)
Molecular cloning of a rat testis form of the inhibitor protein of cAMP-dependent protein kinase. (1991) (45)
Characteristics of the adenohypophyseal Ca2+-phospholipid-dependent protein kinase (1984) (45)
Possibility of shape conformers of the protein inhibitor of the cyclic adenosine monophosphate dependent protein kinase. (1979) (43)
Rapid method for preparation of crystalline human ceruloplasmin from Cohn fraction IV-1. (1962) (42)
Expression in Escherichia coli and characterization of the heat-stable inhibitor of the cAMP-dependent protein kinase. (1991) (41)
16 Protein Kinases (1973) (40)
Circular dichroic evidence for an ordered sequence of ligand/binding site interactions in the catalytic reaction of the cAMP-dependent protein kinase. (1985) (40)
Structural basis for the low affinities of yeast cAMP-dependent and mammalian cGMP-dependent protein kinases for protein kinase inhibitor peptides. (1992) (40)
Utilization of the inhibitor protein of adenosine cyclic monophosphate-dependent protein kinase, and peptides derived from it, as tools to study adenosine cyclic monophosphate-mediated cellular processes. (1991) (40)
Substrate diversity of the cAMP-dependent protein kinase: regulation based upon multiple binding interactions. (1992) (38)
The alpha- and beta-isoforms of the inhibitor protein of the 3',5'-cyclic adenosine monophosphate-dependent protein kinase: characteristics and tissue- and developmental-specific expression. (1992) (38)
Fluorescence resonance energy transfer within a heterochromatic cAMP-dependent protein kinase holoenzyme under equilibrium conditions: new insights into the conformational changes that result in cAMP-dependent activation. (1993) (35)
A Structural Model of the Catalytic Subunit-regulatory Subunit Dimeric Complex of the cAMP-dependent Protein Kinase* (2002) (34)
Subunit phosphorylation and activation of skeletal muscle phosphorylase kinase by the cAMP-dependent protein kinase. Divalent metal ion, ATP, and protein concentration dependence. (1985) (33)
10 Phosphorylase Kinase (1986) (32)
CHAPTER 1 – The Physiological Regulation and Function of cAMP-Dependent Protein Kinases (1979) (32)
Conformational analysis of PKI(5-22)amide, the active inhibitory fragment of the inhibitor protein of the cyclic AMP-dependent protein kinase. (1989) (32)
A rapid method for the measurement of [gamma-32P]ATP specific radioactivity in tissue extracts and its application to the study of 32Pi uptake in perfused rat heart. (1976) (31)
Autophosphorylation of phosphorylase kinase. Divalent metal cation and nucleotide dependency. (1983) (30)
Purification and properties of the cardiac isoenzyme of phosphorylase kinase. (1980) (27)
Role of the cAMP-dependent protein kinase as the transducer of cAMP action. (1978) (27)
Histone 4 phosphotransferase activities in proliferating lymphocytes. Partial purification and characterization of an enzyme specific for Ser-47. (1977) (25)
Cyclic AMP-dependent and cyclic AMP-independent antagonism of insulin activation of cardiac glycogen synthase. (1982) (25)
Krebs EG: Purification and characterization of a protein inhibitor of adenosine 3',5'-monophosphate-dependent protein kinases. (1971) (25)
Histone 1 phosphotransferase activities during the maturation of oocytes of Xenopus laevis. (1979) (25)
Phosphorylation and dephosphorylation of phosphorylase kinase in the perfused rat heart. (1979) (24)
Cytochemical identification of the regulatory subunit of the cAMP-dependent protein kinase by use of fluorescently labeled catalytic subunit. Examination of protein kinase dissociation in hepatoma cells responding to 8-Br-cAMP stimulation. (1986) (24)
High and intermediate affinity calmodulin binding domains of the alpha and beta subunits of phosphorylase kinase and their potential role in phosphorylation-dependent activation of the holoenzyme. (1992) (22)
Inhibitor protein of the cAMP-dependent protein kinase: characteristics and purification. (1983) (22)
Circular dichroic investigations of secondary structure in synthetic peptide inhibitors of cAMP-dependent protein kinase: a model for inhibitory potential. (1987) (22)
Receptor-mediated action without receptor occupancy: a function for cell-cell communication in ovarian follicles. (1987) (22)
Purification of a physiological form of the inhibitor protein of the cAMP-dependent protein kinase. (1982) (22)
Tyrosine kinase catalyzed phosphorylation and inactivation of the inhibitor protein of the cAMP-dependent protein kinase. (1987) (21)
Analysis by mutagenesis of the ATP binding site of the gamma subunit of skeletal muscle phosphorylase kinase expressed using a baculovirus system. (1992) (20)
Phosphorylation of glycogen synthase in the perfused rat heart. (1979) (20)
Cyclic AMP-dependent protein kinases from skeletal muscle and liver. (1972) (20)
Hormonal regulation of the phosphorylation of glycogen synthase in perfused rat heart. Effects of insulin, catecholamines, and glucagon. (1983) (19)
CHANGES IN THE ACTIVITIES OF D-GLYCERATE AND D-3-PHOSPHOGLYCERATE DEHYDROGENASES IN THE DEVELOPING RAT LIVER. (1964) (18)
Motifs of protein phosphorylation and mechanisms of reversible covalent regulation. (1991) (18)
The receptor protein for cyclic AMP in the control of glycogenolysis. (1970) (16)
A reinvestigation of the kinetic parameters of phosphoenolypyruvate carboxykinase. (1971) (16)
Multiplicity of the β Form of the cAMP-dependent Protein Kinase Inhibitor Protein Generated by Post-translational Modification and Alternate Translational Initiation* (1997) (15)
Metabolism of N6,O2'-[3H]dibutyryl cyclic adenosine 3',5'-monophosphate and macromolecular interactions of the products perfused rat liver. (1977) (15)
Specific Testicular Cellular Localization and Hormonal Regulation of the PKIα and PKIβ Isoforms of the Inhibitor Protein of the cAMP-dependent Protein Kinase* (1997) (15)
Characterization of the gene for rat phosphorylase kinase catalytic subunit. (1993) (14)
Asymptomatic McArdle's disease associated with hyper-creatine kinase-emia and absence of myophosphorylase (1998) (14)
Protein phosphotransferase activities and cyclic nucleotide action in proliferating lymphocytes. (1976) (14)
Nucleotide sequence of cDNA encoding the catalytic subunit of phosphorylase kinase from rat soleus muscle. (1988) (13)
A dual-specificity isoform of the protein kinase inhibitor PKI produced by alternate gene splicing. (2002) (13)
Synthesis, characterization and inhibitory activities of (4-N3[3,5-3H]Phe10)PKI(6-22)amide and its precursors: photoaffinity labeling peptides for the active site of cyclic AMP-dependent protein kinase. (2009) (13)
Characterization of multiple charge isomers of the inhibitor protein of the cyclic AMP-dependent protein kinase from bovine heart and rabbit skeletal muscle. (1980) (12)
Characterization of the isolated rat flexor digitorum brevis for the study of skeletal muscle phosphorylase kinase phosphorylation. (1987) (12)
Phosphorylation and activation of the cardiac isoenzyme of phosphorylase kinase by the cAMP-dependent protein kinase. (1981) (12)
McArdle's disease heterozygotes. Metabolic adaptation assessed using 31P-nuclear magnetic resonance. (1986) (11)
A kinetic re-interpretation of the regulation of rabbit skeletal-muscle phosphorylase kinase activity by Ca2+ and phosphorylation. (1992) (11)
Cardiac phosphorylase kinase. Modulation of the activity by cAMP-dependent and cAMP-dependent phosphorylation of the alpha- subunit. (1982) (10)
Solution structure of phosphorylase kinase studied using small-angle X-ray and neutron scattering. (1992) (10)
Control of phosphorylase kinase in the isolated glycogen particle by Ca2+-Mg2+ synergistic activation and cAMP-dependent phosphorylation. (1986) (9)
Conformationally constrained analogs of protein kinase inhibitor(6–22)amide: Effect of turn structures in the center of the peptide on inhibition of cAMP‐dependent protein kinase (1995) (8)
The inhibitor protein of the cyclic AMP-dependent protein kinase-catalytic subunit interaction. Composition of multiple complexes. (1988) (8)
Decrease in force potentiation and appearance of α-adrenergic mediated contracture in aging rat skeletal muscle (1987) (8)
D-3-phosphoglycerate dehydrogenase. Further studies on the enzyme isolated from chicken liver. (1967) (7)
Expression of a cDNA for the catalytic subunit of skeletal-muscle phosphorylase kinase in transfected 3T3 cells. (1989) (7)
Indices of the activation state of glycogen synthase. (1980) (7)
Purification and characterization of an inhibitor protein of cyclic AMP-dependent protein kinases. (1974) (7)
Criteria for the classification of protein kinases. (1974) (7)
Expressed phosphorylase b kinase and its alphagammadelta subcomplex as regulatory models for the rabbit skeletal muscle holoenzyme. (2009) (7)
Subunit phosphorylation and activation of phosphorylase kinase in perfused rat hearts. (1987) (7)
Coordinated expression of phosphorylase kinase subunits in regenerating skeletal muscle. (1992) (6)
Preparation and properties of N6-monobutyryl adenosine 5'-monophosphate. A major hepatic metabolite of N6,O2'-dibutyryl cyclic adenosine 3':5'-monophosphate. (1977) (6)
Regulation of cardiac glycogen synthase by phosphorylation: catalysis of inactivation by cAMP-dependent and cAMP-independent protein kinases and comparison with the phosphorylation of the skeletal muscle enzyme. (1982) (5)
Cardiac phosphorylase kinase. Deactivation by selective dephosphorylation of alpha' and beta subunits. (1982) (5)
Developmental-Specific Expression (1992) (4)
Cardiac phosphorylase kinase: preparation and properties. (1983) (4)
Baculovirus-mediated overexpression of the phosphorylase b kinase holoenzyme and alpha gamma delta and gamma delta subcomplexes. (2004) (4)
Regulation of cardiac glycogen synthase. (1983) (3)
Neural regulation of the formation of skeletal muscle phosphorylase kinase holoenzyme in adult and developing rat muscle. (1997) (3)
The non-identity of protein phosphatase deinhibitor and protein kinase inhibitor (1984) (2)
[46] Cytoplasmic hepatic protein kinases (1974) (2)
The control of phosphorylase kinase phosphatase activity by polycations and the deinhibitor protein. (1984) (2)
Identification of Functional Domains of the Inhibitor Protein of Camp-Dependent Protein Kinase (1987) (2)
Lengthy incubation for homosexual transmission of acquired immunodeficiency syndrome in a 79 year old man. (1989) (2)
Calcium-dependent regulation of phosphorylase activation in a fast-twitch oxidative-glycolytic skeletal muscle. (1988) (2)
Direct cytochemical localization of regulatory subunit of cAMP-dependent protein kinase using fluoresceinated catalytic subunit. (1988) (2)
Modulation of Nuclear Protein Kinase Activity by Glucagon (1977) (1)
The Mechanism of Action of Cyclic AMP in the Activation of Phosphorylase Kinase (1972) (1)
Metabolic Adaptation Assessed Using 31P-Nuclear Magnetic Resonance (1986) (1)
Differentiation-dependent mechanisms of transcriptional regulation of the catalytic subunit of phosphorylase kinase. (2002) (1)
Characterization of cyclic gmp binding in cortisol-resistant lymphosarcoma p1798. Abstr. (1974) (1)
MODEL STRUCTURE OF THE CATALYTIC SUBUNIT-REGULATORY SUBUNIT DIMERIC COMPLEX OF THE C-AMP-DEPENDENT PROTEIN KINASE (2002) (0)
Cytoplasmic hepatic protein kinases. (1974) (0)
Solution structure analysis of the conformational changes that occur upon the binding of the protein kinase inhibitor peptide to the catalytic subunit of the cAMP dependent protein kinase (1994) (0)
Structural modeling of the catalytic subunit-regulatory subunit dimeric complex of the camp-dependent protein kinase. (2001) (0)
Catlysis of the phosphrylaseinase actition reaction. (1971) (0)
Printed in Great Britain Nuclear Protein Kinase Activity in Glucagon-Stimulated Perfused Rat Livers (2005) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Donal A. Walsh?

Donal A. Walsh is affiliated with the following schools:

University of California, Davis